Abstract：Objective To investigate trends in the disease burden of tumors among children aged 0 to 14 years in China in 1990 and 2019, so as to provide insights into management of pediatric tumors in China. Methods The Global Burden of Disease 2019 data were retrieved from the Global Health Data Exchange, and the mortality and disability adjusted life years (DALYs) of pediatric tumors were evaluated among children at ages of 0 to 14 years in China in 1990 and 2019, and the disease burdens due to pediatric tumors in China were compared with the regions with different social population index (SDI). Results The mortality of tumors decreased from 13.10/105 in 1990 to 4.96/105 in 2019 (a 62.17% reduction) among children aged 0 to 14 years in China, and the DALY rate decreased from 1 118.93/105 to 424.77/105 (a 62.04% reduction). The mortality and DALY rate of tumors decreased from 13.48/105 to 5.38/105, and from 1 147.09/105 to 458.65/105 among male children, and from 12.69/105 to 4.46/105, and from 1 088.22/105 to 384.94/105 among female children. The disease burden of pediatric tumors was concentrated among children at ages of 0 to 4 years. The three highest disease burdens of pediatric tumors were measured in leukemia, brain and nerve system tumors, and lymphoma in 2019. Compared with the regions with different SDI, the largest reductions were seen in the mortality and DALY rate of tumors among children at ages of 0 to 14 years in China, which were still higher than in middle, high-middle and high SDI regions. Conclusions The disease burden of tumors declined among children at ages of 0 to 14 years in China in 2019, compared with 1990; however, it is still higher than in middle and higher SDI regions. The disease burden of pediatric tumors was high among children at ages of 0 to 4 years and among male children, with leukemia, brain and nerve system tumors and lymphoma as predominant types.
周洁, 谭自明, 茹凉. 1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J]. 预防医学, 2023, 35(3): 205-209.
ZHOU Jie, TAN Ziming, RU Liang. Disease burden of tumors among children aged 0 to 14 years in Chinain 1990 and 2019. Preventive Medicine, 2023, 35(3): 205-209.
[1] WINTHER J F,KENBORG L,BYRNE J,et al.Childhood cancer survivor cohorts in Europe[J].Acta Oncol,2015,54(5):655-668. [2] FORCE L M,ABDOLLAHPOUR I,ADVANI S M,et al.The global burden of childhood and adolescent cancer in 2017:an analysis of the Global Burden of Disease Study 2017[J].Lancet Oncol,2019,20(9):1211-1225. [3] GAUDIN N.International Childhood Cancer Day:much remains to be Done to Fight Childhood Cancer[M].Lyon:International Agency for Research on Cancer,2016. [4] ZHU B,WU X M,AN W X,et al.The systematic analysis and 10-year prediction on disease burden of childhood cancer in China[J].Front Public Health,2022,10:12. [5] 周艳玲,安嘉璐,田玲.我国儿童恶性肿瘤的流行病学分析[J].中国当代儿科杂志,2015,17(7):649-654. [6] NAGHAVI M,ABAJOBIR A A,ABBAFATI C,et al.Global,regional,and national age-sex specific mortality for 264 causes of death,1980-2016:a systematic analysis for the Global Burden of Disease Study 2016[J].Lancet,2017,390(10100):1151-1210. [7] DJALALINIA S,MOGHADDAM S S,MORADI-LAKEH M,et al.Prevalence and years lived with disability of 310 diseases and injuries in iran and its neighboring countries,1990-2015:findings from Global Burden of Disease Study 2015[J].Arch Iran Med,2017,20(7):392-402. [8] 崔怡然,宇传华.基于全球视角下的中国结核病负担现状与趋势分析[J].中华疾病控制杂志,2020,24(3):258-263. [9] KOCARNIK J M,COMPTON K,DEAN F E,et al.Cancer incidence,mortality,years of life lost,years lived with disability,and disability-adjusted life years for 29 cancer groups from 2010 to 2019:a systematic analysis for the Global Burden of Disease Study 2019[J].JAMA Oncol,2022,8(3):420-444. [10] ABBAFATI C,ABBAS K M,ABBASI M,et al.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222. [11] ZOU J,SUN T,SONG X,et al.Distributions and trends of the global burden of COPD attributable to risk factors by SDI,age,and sex from1990 to 2019:a systematic analysis of GBD 2019 data[J/OL].Respir Res,2022,23(1)[2023-02-06].https://doi.org/10.1186/s12931-022-02011-y. [12] ZHENG R S,PENG X X,ZENG H M,et al.Incidence,mortality and survival of childhood cancer in China during 2000-2010 period:a population-based study[J].Cancer Lett,2015,363(2):176-180. [13] SUN K X,ZHENG R S,ZHANG S W,et al.Patterns and trends of cancer incidence in children and adolescents in China,2011-2015:a population-based cancer registry study[J].Cancer Med,2021,10(13):4575-4586. [14] DORAK M T,KARPUZOGLU E.Gender differences in cancer susceptibility:an inadequately addressed issue [J/OL].Front Genet,2012,3[2023-02-06].https://doi.org/10.3389/fgene.2012.00268. [15] GINSBERG G L.Assessing cancer risks from short-term exposures in children[J].Risk Anal,2003,23(1):19-34. [16] 倪建晓,吴文秀,苏依所,等.2013—2020年瓯海区居民恶性肿瘤死亡趋势及减寿分析[J].预防医学,2022,34(4):413-418. [17] SIEGEL R L,MILLER K D,FUCHS H E,et al.Cancer Statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33. [18] 张艳,刘庆敏,刘冰,等.2006—2015年杭州市居民白血病死亡趋势分析[J].预防医学,2019,31(8):782-785. [19] ATUN R,BHAKTA N,DENBURG A,et al.Sustainable care for children with cancer:a Lancet Oncology Commission[J].Lancet Oncol,2020,21(4):185-224. [20] JIN Y,LYU Q.Basic research in childhood cancer:progress and future directions in China[J].Cancer Lett,2020,495:156-164. [21] NI X,LI Z,LI X,et al.Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China:a cross-sectional study[J].Lancet,2022,400(10357):1020-1032.
